In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Spyre Therapeutics Inc (NASDAQ: SYRE) was $25.26 for the day, up 3.44% from the previous closing price of $24.42. In other words, the price has increased by $3.44 from its previous closing price. On the day, 0.74 million shares were traded. SYRE stock price reached its highest trading level at $25.34 during the session, while it also had its lowest trading level at $23.14.
Ratios:
Our analysis of SYRE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.32 and its Current Ratio is at 7.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on September 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $45.
On May 02, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $50.Robert W. Baird initiated its Outperform rating on May 02, 2024, with a $50 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 06 ’24 when Albers Jeffrey W. sold 6,700 shares for $36.76 per share. The transaction valued at 246,313 led to the insider holds 27,360 shares of the business.
Albers Jeffrey W. sold 300 shares of SYRE for $10,929 on Oct 25 ’24. The Director now owns 34,060 shares after completing the transaction at $36.43 per share. On Oct 25 ’24, another insider, SESSIONS, LLC, who serves as the Director of the company, bought 7,000 shares for $33.70 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRE now has a Market Capitalization of 1482918656 and an Enterprise Value of 1040745600. As of this moment, Spyre’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.74.
Stock Price History:
Over the past 52 weeks, SYRE has reached a high of $47.97, while it has fallen to a 52-week low of $15.37. The 50-Day Moving Average of the stock is -17.23%, while the 200-Day Moving Average is calculated to be -19.73%.
Shares Statistics:
SYRE traded an average of 579.56K shares per day over the past three months and 481970 shares per day over the past ten days. A total of 51.40M shares are outstanding, with a floating share count of 50.01M. Insiders hold about 14.81% of the company’s shares, while institutions hold 81.99% stake in the company. Shares short for SYRE as of 1732838400 were 8859758 with a Short Ratio of 15.29, compared to 1730332800 on 8250593. Therefore, it implies a Short% of Shares Outstanding of 8859758 and a Short% of Float of 17.419999999999998.
